Related Articles
A phase II study of vinorelbine in patients with advanced non-small cell lung cancer
A feasibility study of bevacizumab and vinorelbine in patients with previously treated advanced non‑squamous non-small‑cell lung cancer
Heat shock protein 27 is a potential indicator for response to YangZheng XiaoJi and chemotherapy agents in cancer cells
Pemetrexed versus vinorelbine treatment of advanced non‑squamous non-small cell lung cancer in elderly patients
RESULTS OF A CLINICAL MULTICENTRIC RANDOMIZED PHASE-II STUDY OF NONSMALL CELL LUNG-CANCER TREATED WITH VINORELBINE CISPLATIN VERSUS VINORELBINE ALONE